Insights into photodynamic therapy dosimetry: simultaneous singlet oxygen luminescence and photosensitizer photobleaching measurements.

[1]  T J Dougherty,et al.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.

[2]  M. Orrit,et al.  Photoblinking of Rhodamine 6G in Poly(vinyl alcohol): Radical Dark State Formed through the Triplet , 2003 .

[3]  T. Foster,et al.  Singlet Oxygen‐Versus Nonsinglet Oxygen‐Mediated Mechanisms of Sensitizer Photobleaching and Their Effects on Photodynamic Dosimetry , 1998, Photochemistry and photobiology.

[4]  S. Mitra,et al.  Photodynamic therapy: Biophysical mechanisms and molecular responses , 2004 .

[5]  Herbert C Wolfsen,et al.  The role of photodynamic therapy in the esophagus. , 2010, Gastrointestinal endoscopy clinics of North America.

[6]  R. Kołos,et al.  Optimal oxygen concentration for the detection of single indocarbocyanine molecules in a polymeric matrix , 2005 .

[7]  Thomas H. Foster,et al.  In Vivo mTHPC Photobleaching in Normal Rat Skin Exhibits Unique Irradiance-dependent Features¶ , 2002, Photochemistry and photobiology.

[8]  M S Patterson,et al.  Modeling of photosensitizer fluorescence emission and photobleaching for photodynamic therapy dosimetry. , 1998, Applied optics.

[9]  M S Patterson,et al.  Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid , 2005, British Journal of Cancer.

[10]  B. Wilson,et al.  The Influence of Oxygen Depletion and Photosensitizer Triplet‐state Dynamics During Photodynamic Therapy on Accurate Singlet Oxygen Luminescence Monitoring and Analysis of Treatment Dose Response , 2011, Photochemistry and photobiology.

[11]  B. Wilson,et al.  The physics, biophysics and technology of photodynamic therapy , 2008, Physics in medicine and biology.

[12]  Henricus J C M Sterenborg,et al.  The importance of in situ dosimetry during photodynamic therapy of Barrett's esophagus. , 2006, Gastrointestinal endoscopy.

[13]  Jarod C Finlay,et al.  Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms. , 2004, Physics in medicine and biology.

[14]  Michael S Patterson,et al.  Relationship Between mTHPC Fluorescence Photobleaching and Cell Viability During In Vitro Photodynamic Treatment of DP16 Cells¶ , 2002, Photochemistry and photobiology.

[15]  P. Kapusta,et al.  Time-resolved methods in biophysics. 7. Photon counting vs. analog time-resolved singlet oxygen phosphorescence detection , 2008, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[16]  H Sterenborg,et al.  Phosphorescence-Fluorescence ratio imaging for monitoring the oxygen status during photodynamic therapy. , 2004, Optics express.

[17]  Michael S Patterson,et al.  In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy. , 2003, Cancer research.

[18]  Michael S Patterson,et al.  Calculation of Singlet Oxygen Dose from Photosensitizer Fluorescence and Photobleaching During mTHPC Photodynamic Therapy of MLL Cells ¶ , 2005, Photochemistry and photobiology.

[19]  Jan C. Schlothauer,et al.  New insights to primary photodynamic effects--Singlet oxygen kinetics in living cells. , 2010, Journal of photochemistry and photobiology. B, Biology.

[20]  V. S. Bagnato,et al.  Phototransformation of hematoporphyrin in aqueous solution: Anomalous behavior at low oxygen concentration , 2009 .

[21]  Jarod C Finlay,et al.  The role of photodynamic therapy (PDT) physics. , 2008, Medical physics.

[22]  V. Sandoghdar,et al.  Oxygen-dependent photochemistry of fluorescent dyes studied at the single molecule level , 2006 .

[23]  Can Ince,et al.  Mitochondrial PO2 measured by delayed fluorescence of endogenous protoporphyrin IX , 2006, Nature Methods.

[24]  Kai Zhang,et al.  Techniques for delivery and monitoring of TOOKAD(WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities , 2005, SPIE BiOS.

[25]  Michael S Patterson,et al.  Singlet Oxygen Luminescence Dosimetry (SOLD) for Photodynamic Therapy: Current Status, Challenges and Future Prospects , 2006, Photochemistry and photobiology.

[26]  R. Schmidt.  Photosensitized Generation of Singlet Oxygen , 2006, Photochemistry and photobiology.

[27]  Michael S Patterson,et al.  Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions , 2006, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[28]  J. Kanofsky,et al.  Direct observation of singlet oxygen phosphorescence at 1270 nm from L1210 leukemia cells exposed to polyporphyrin and light. , 1991, Archives of biochemistry and biophysics.

[29]  R. Bonnett,et al.  Photobleaching of 5,10,15,20-tetrakis(m-hydroxyphenyl)porphyrin (m-THPP) and the corresponding chlorin (m-THPC) and bacteriochlorin(m-THPBC). A comparative study , 1999 .

[30]  L. Lilge,et al.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm , 1997, Lasers in Medical Science.

[31]  Stefan Andersson-Engels,et al.  Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements. , 2005, Applied optics.